Silverfin false false 31/03/2024 31/03/2024 01/04/2023 no description of principal activity Dr A Prendergast 18/02/2015 Dr B D Prendergast 18/02/2015 Dr B D Prendergast 09446657 2024-03-31 09446657 bus:Director1 2024-03-31 09446657 bus:Director2 2024-03-31 09446657 2023-03-31 09446657 core:CurrentFinancialInstruments 2024-03-31 09446657 core:CurrentFinancialInstruments 2023-03-31 09446657 2023-04-01 2024-03-31 09446657 bus:Micro-entities 2023-04-01 2024-03-31 09446657 bus:FilletedAccounts 2023-04-01 2024-03-31 09446657 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 09446657 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09446657 bus:Director1 2023-04-01 2024-03-31 09446657 bus:Director2 2023-04-01 2024-03-31 09446657 bus:Director3 2023-04-01 2024-03-31 09446657 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Company No: 09446657 (England and Wales)

BERNARD PRENDERGAST CARDIOLOGY LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH THE REGISTRAR

BERNARD PRENDERGAST CARDIOLOGY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024

Contents

BERNARD PRENDERGAST CARDIOLOGY LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024
BERNARD PRENDERGAST CARDIOLOGY LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024
DIRECTORS Dr A Prendergast
Dr B D Prendergast
REGISTERED OFFICE Flat 2
2
Warwick Square Flat 2
Number 2
Warwick Square
London
SW1V 2AA
United Kingdom
COMPANY NUMBER 09446657 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
264 Banbury Road
Oxford
OX2 7DY
BERNARD PRENDERGAST CARDIOLOGY LIMITED

BALANCE SHEET

AS AT 31 MARCH 2024
BERNARD PRENDERGAST CARDIOLOGY LIMITED

BALANCE SHEET (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024
2024 2023
£ £
Fixed assets 36,898 34,866
Current assets 67,870 61,188
Prepayments and accrued income 210 -
Creditors: amounts falling due within one year ( 11,794) ( 5,363)
Net current assets 56,286 55,825
Total assets less current liabilities 93,184 90,691
Accruals and deferred income ( 2,280) ( 2,076)
Net assets 90,904 88,615
Capital and reserves 90,904 88,615

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Bernard Prendergast Cardiology Limited (registered number: 09446657) were approved and authorised for issue by the Board of Directors on 15 January 2025 and were signed on its behalf by:

Dr B D Prendergast
Director
BERNARD PRENDERGAST CARDIOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024
BERNARD PRENDERGAST CARDIOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 09446657). The address of its registered office is Flat 2, 2, Warwick Square Flat 2, Number 2, Warwick Square, London, SW1V 2AA, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2

3. Directors’ benefits: advances, credit and guarantees

Advances

During the year the directors withdrew funds from the company totalling £9,835 (2023: £8,016). The directors introduced funds totalling £1,310 (2023: £5,040). At the balance sheet date £19,122 (2023: £10,329) remains due to the company and is included with the other debtors.
Interest of £267 (2023: £173) has been charged on amounts due from the director at the official HMRC rate interest.